Friday, April 07, 2006

ADHD Patch Receives FDA Approval

From the Associated Press:
The FDA on Thursday approved the first skin patch to treat attention deficit hyperactivity disorder in children.

The patch called Daytrana, designed to be worn for 9 hours, contains methylphenidate, which has been shown to help children with ADHD. It is the same stimulant that is in Ritalin. The patch is made by Noven Pharmaceuticals Inc. of Miami.

In December, a Food and Drug Administration panel of independent experts voted to recommend that the patch's label encourage its use as an alternative treatment for children ages 6 to 12 with ADHD, meaning doctors should prescribe it only if taking pills is too difficult for a child.

Unlike pill forms of the drug, the patch can be removed if it causes side effects.

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home